Shanghai Model Organisms Center (SHSE:688265) EBIT: ¥34.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688265 Shanghai Model Organisms Center Inc SHSE:688265
78 GF Score
Price ¥31.60
GF Value ¥47.95
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Model Organisms Center EBIT?

Shanghai Model Organisms Center SHSE:688265 -2.20% 78 EBIT is ¥34.0 Mil as of Mar. 2026. GuruFocus rates SHSE:688265 with a GF Score™ of 78/100 and a GF Value™ of ¥47.95 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Shanghai Model Organisms Center's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ¥1.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥34.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shanghai Model Organisms Center's annualized ROC % for the quarter that ended in Mar. 2026 was 0.94%. Shanghai Model Organisms Center's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 0.93%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Shanghai Model Organisms Center's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.16%.


Shanghai Model Organisms Center  (SHSE:688265) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shanghai Model Organisms Center's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=8.868 * ( 1 - 0% )/( (920.288 + 968.699)/ 2 )
=8.868/944.4935
=0.94 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1983.523 - 97.968 - ( 1033.54 - max(0, 215.969 - 1181.236+1033.54))
=920.288

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1965.743 - 76.834 - ( 931.99 - max(0, 190.358 - 1110.568+931.99))
=968.699

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Shanghai Model Organisms Center's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3.808/( ( (403.311 + max(-55.623, 0)) + (416.243 + max(1.649, 0)) )/ 2 )
=3.808/( ( 403.311 + 417.892 )/ 2 )
=3.808/410.6015
=0.93 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(112.379 + 18.716 + 13.515) - (97.968 + 0 + 102.265)
=-55.623

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(133.055 + 26.765 + 15.789) - (76.834 + 0 + 97.126)
=1.649

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Shanghai Model Organisms Center's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=34.04/1573.503
=2.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Model Organisms Center EBIT Related Terms


Shanghai Model Organisms Center EBIT Historical Data

* Premium members only.

The historical data trend for Shanghai Model Organisms Center's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Model Organisms Center EBIT Chart

Shanghai Model Organisms Center Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.53 -9.53 -24.86 6.53 31.52

Shanghai Model Organisms Center Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.57 20.54 8.62 3.93 0.95

SHSE:688265 vs VRTX, REGN, RVMD: EBIT Comparison

For the Biotechnology subindustry, Shanghai Model Organisms Center's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Model Organisms Center EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Model Organisms Center's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shanghai Model Organisms Center's EV-to-EBIT falls into.


SHSE:688265
78GF Score
Shanghai Model Organisms Center Inc SHSE:688265
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Model Organisms Center EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥34.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ¥34.0 Mil mean?
Shanghai Model Organisms Center (SHSE:688265) has a EBIT of ¥34.0 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Shanghai Model Organisms Center.
Is Shanghai Model Organisms Center's EBIT too high?
Shanghai Model Organisms Center's current EBIT is ¥34.0 Mil. Overall, Shanghai Model Organisms Center has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Model Organisms Center's EBIT compare to VRTX and REGN?
Shanghai Model Organisms Center's EBIT of ¥34.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Shanghai Model Organisms Center. Shanghai Model Organisms Center's current EBIT is ¥34.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Model Organisms Center stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Model Organisms Center (SHSE:688265) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥47.95, compared to a current price of ¥31.60 — trading 34.1% below its estimated fair value. The current EBIT is ¥34.0 Mil. Shanghai Model Organisms Center's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Shanghai Model Organisms Center (SHSE:688265), the current EBIT is ¥34.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Model Organisms Center (SHSE:688265) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Model Organisms Center stock appears to be undervalued. The current stock price of ¥31.60 is trading 34.1% below its estimated GF Value™ of ¥47.95. GuruFocus considers Shanghai Model Organisms Center to be Significantly Undervalued.

Key valuation signals for SHSE:688265:

  • EBIT: ¥34.0 Mil
  • GF Value™: ¥47.95 vs. price of ¥31.60 (34.1% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Model Organisms Center Business Description

Address No.178 Banxia Road, Floor 2-4, Building 2, Pudong New Area, Shanghai, CHN, 201318
Shanghai Model Organisms Center Inc is engaged in model organisms and is dedicated to gene editing and life decoding. It provides customized solutions such as genetically engineered animal models, phenotype analysis and high-throughput screenings to advance life science research and drug discovery.
78GF Score

Get the complete analysis for SHSE:688265

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.60
Price
¥47.95
GF Value